Skip to main contentSkip to navigationSkip to search

Curasight presents at Bio Stock Life Science Spring Summit

May 26, 2021


Curasight A/S CEO Ulrich Krasilnikoff will present the company and its future plans at Bio Stock Life Science Spring Summit Thursday 27 May 2021. 

The presentation will be webcasted live 11:20 (CET), Thursday 27 May 2021.

For more information please click here

For more information regarding Curasight, please contact:

Ulrich Krasilnikoff,

CEO Phone: +45 22 83 01 60


Curasight is a clinical development company based in Copenhagen, Denmark. The company is a pioneer in the field of exploiting a novel Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (“uPAR”). The technology is expected to improve diagnosis and risk stratification in multiple cancer types.